Atraumatic painful swollen lower extremity has limited differential diagnosis and in patients with risk factors for venous thromboembolism offers little challenge. Poor awareness of rare entities results in misdiagnosis and mismanagement. Diabetic muscle infarction is a rare complication of longstanding uncontrolled diabetes mellitus causing ischemic skeletal myonecrosis and similar presentation.
CASE REPORT
A 49 year-old Jordanian man with a history of hypertension and type II diabetes mellitus diagnosed 10 years ago (after a significant period of delay in seeking medical care due to insurance issues) presented with pain and swelling of the left thigh that started 4 weeks before presentation. The pain progressively affected his activity and suddenly became so severe that he could not bear his own weight and was worse with ambulation. He had no pain in other muscle groups or joints. He denied heavy exertion, injury, trauma or falls before the onset of symptoms.
He had no recent viral or other febrile illnesses. The patient works as a taxi driver; he is a heavy smoker for the last 30 years (30 pack-years). He denied alcohol intake or illicit drug use, his medication at time of presentation included mixtard insulin, enalapril, amlodipine, furosemide, aspirin and multivitamins.
One year before the onset of his current left thigh presentation he underwent excision for a painful right thigh mass but he lost follow up and histopathological diagnosis was not available at time of admission. Based on the above findings and after excluding other causes of painful extremity in a patient with diabetes mellitus diagnosis of recurrent diabetic muscle infarction was made. Patient was treated with bed rest and analgesics, and his blood sugar was controlled. He was given intravenous methylprednisolone 80 mg for 7 days, changed to prednisolone 30 mg daily gradually tapered over 2 weeks. His condition and his lab tests improved, he was able to walk and was discharged from the hospital after 4 weeks.
All investigations conform to standards currently applied in Jordan.
DISCUSSION
Diabetic muscle infarction or spontaneous diabetic myonecrosis is a rare vascular complication of longstanding uncontrolled diabetes mellitus that refers to ischemic skeletal muscle necrosis.
Due to poor awareness of this rare diabetic complication and presence of many more common conditions that have similar presentations, it is often misdiagnosed or underdiagnosed; it was first reported in 1965 by Angervall and Stener (1) and there have been fewer than 100 patients reported since 1965. DMI typically presents as a localized atraumatic severe painful and tender swelling of acute onset (but sometimes can be subacute or subtle) especially in the lower extremities usually not associated with systemic signs.
It often affects the thighs; with the quadriceps being involved in 83%of cases, and it rarely affects the calf muscles (2). Bilateral involvement occurred in one third of the patients (3).
Recurrence at the same or different site occurred in about 45% of 84 patients reviewed (4).
About 97% of patients had other microvascular complications including nephropathy, retinopathy or neuropathy (4). With regard to age, the mean age of onset was 42 years (5).
The pathogenesis of DMI is still unclear but a diffuse microangiopathic process possibly associated with hypoxia perfusion injury has been implicated as a cause (6-8).
Poor controlled diabetes has been strongly associated with the development of DMI; most of the known cases of DMI had HbA1C greater than 7% (5).
DMI is a rare and easily misdiagnosed condition that occurs in patients with long standing diabetes, laboratory tests are usually not specific, about three -quarters had ESR greater than 50 mm /hour. One third had leukocytosis, and half only had elevated CK (5).
The diagnosis of DMI should be included in the differential diagnosis in a patient with long standing history of diabetes (especially with microvascular complications) presenting with unexplained sudden painful localized swelling in the lower extremities.
The diagnosis can be confirmed by magnetic resonance imaging (MRI) of the affected extremity, and /or muscle biopsy of the affected muscle(s). MRI is the preferred diagnostic tool; abnormal MRI findings have been reported in all patients with DMI. T2 weighted sequences shows characteristic features of extensive oedema within the muscle(s), muscle enlargement, subcutaneous and interfascial oedema. The most characteristic is multifocal areas of involvement in a patchwork pattern (6, 9, 10).
Muscle biopsy is not advisable, and often not needed for the diagnosis of DMI, as it may be associated with delayed recovery (11) . The biopsy when performed shows pale muscle on gross examination, irregular areas of haemorrhage, necrosis of myocytes with regeneration, and atrophy of surrounding fibers and hyalinosis and thickening of arterioles (1, 12, 13) . In our case excisional muscle biopsy was performed in the first time because of the unawareness of this condition by treating physician, we avoided biopsy in the second time.
The infrequent presentation of this condition makes retrospective literature review the source of valuable information concerning the management of this condition. Most literature supports conservative management with bed rest, avoidance of weight bearing, analgesia, tight control of diabetes, and anti-inflammatory drugs, including steroids (5). The patient symptoms improves (as in this case) after treatment with steroids. Surgery may delay recovery (4).
The recovery period can last for 6 -8 weeks with bed rest and analgesia, with a recurrence rate of 40%. Recurrence may not affect the same muscle group (4). The short term prognosis is good. More ominous, however, is the underlying vascular disease that DMI is associated with.
The cause of death were mainly due to macrovascular events such myocardial infarction, stroke, or gangrene (5). Patients with DMI should undergo evaluation for all end organ manifestation of diabetes.
